Patent · US Active

Method for producing dendritic cells

US8232100B2 · kind B2 · utility

3Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2010
Grant dateJul 31, 2012
Priority date
Expiry dateJul 21, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are embryonic stem cell-derived dendritic cells, genetically modified immature dendritic cells capable of maturation, as well as methods for the production of such cells. In one embodiment, the cells made be produced by a method comprising the steps of providing a population of embryonic stem cells; culturing the embryonic stem cells in the presence of a cytokine or combination of cytokines which brings about differentiation of the embryonic stem cells into dendritic cells; and recovering the dendritic cells from the culture. In a further embodiment, the cells may be genetically modified.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.